{"uri": "eng-9430300", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 100, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Boston", "type": "loc", "score": 91, "label": {"eng": "Boston"}, "location": {"type": "place", "label": {"eng": "Boston"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Royalty_payment", "type": "wiki", "score": 84, "label": {"eng": "Royalty payment"}}, {"uri": "http://en.wikipedia.org/wiki/Shareholder", "type": "wiki", "score": 84, "label": {"eng": "Shareholder"}}, {"uri": "http://en.wikipedia.org/wiki/Cancer_immunotherapy", "type": "wiki", "score": 72, "label": {"eng": "Cancer immunotherapy"}}, {"uri": "http://en.wikipedia.org/wiki/Laboratoires_Servier", "type": "org", "score": 69, "label": {"eng": "Laboratoires Servier"}}, {"uri": "http://en.wikipedia.org/wiki/Pfizer", "type": "wiki", "score": 69, "label": {"eng": "Pfizer"}}, {"uri": "http://en.wikipedia.org/wiki/Protein", "type": "wiki", "score": 69, "label": {"eng": "Protein"}}, {"uri": "http://en.wikipedia.org/wiki/Seagen", "type": "wiki", "score": 61, "label": {"eng": "Seagen"}}, {"uri": "http://en.wikipedia.org/wiki/Monetization", "type": "wiki", "score": 58, "label": {"eng": "Monetization"}}, {"uri": "http://en.wikipedia.org/wiki/Nuclear_fusion", "type": "wiki", "score": 52, "label": {"eng": "Nuclear fusion"}}, {"uri": "http://en.wikipedia.org/wiki/Reverse_takeover", "type": "wiki", "score": 48, "label": {"eng": "Reverse takeover"}}, {"uri": "http://en.wikipedia.org/wiki/Liquidation", "type": "org", "score": 48, "label": {"eng": "Liquidation"}}, {"uri": "http://en.wikipedia.org/wiki/Market_capitalization", "type": "wiki", "score": 42, "label": {"eng": "Market capitalization"}}, {"uri": "http://en.wikipedia.org/wiki/Chairperson", "type": "wiki", "score": 40, "label": {"eng": "Chairperson"}}, {"uri": "http://en.wikipedia.org/wiki/Electromagnetic_spectrum", "type": "wiki", "score": 40, "label": {"eng": "Electromagnetic spectrum"}}, {"uri": "http://en.wikipedia.org/wiki/Business_model", "type": "wiki", "score": 40, "label": {"eng": "Business model"}}, {"uri": "http://en.wikipedia.org/wiki/Economics", "type": "wiki", "score": 40, "label": {"eng": "Economics"}}, {"uri": "http://en.wikipedia.org/wiki/Shareholder_value", "type": "wiki", "score": 31, "label": {"eng": "Shareholder value"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 28, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Dividend", "type": "wiki", "score": 28, "label": {"eng": "Dividend"}}, {"uri": "http://en.wikipedia.org/wiki/Germany", "type": "loc", "score": 28, "label": {"eng": "Germany"}, "location": {"type": "country", "label": {"eng": "Germany"}}}, {"uri": "http://en.wikipedia.org/wiki/Valuation_(finance)", "type": "wiki", "score": 25, "label": {"eng": "Valuation (finance)"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 22, "label": {"eng": "Nasdaq"}}], "eventDate": "2024-03-27", "totalArticleCount": 5, "title": {"eng": "Pieris Pharmaceuticals outlines new cost-saving strategy By Investing.com"}, "summary": {"eng": "BOSTON - Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) announced a strategic shift to focus on potential milestones from its immuno-oncology partnerships, implementing cost-saving measures to extend its cash runway into 2027. The company's Board of Directors, after a comprehensive review, has decided to retain the potential for future milestone and royalty payments rather than pursuing other strategic options.\n\nThe Boston-based biotech firm has ceased all research and development activities, with a "}, "location": {"type": "place", "label": {"eng": "Boston"}, "country": {"type": "country", "label": {"eng": "United States"}}}, "categories": [{"uri": "dmoz/Business/Financial_Services/Venture_Capital", "label": "dmoz/Business/Financial Services/Venture Capital", "wgt": 100}, {"uri": "dmoz/Business/Financial_Services/Cash_Flow", "label": "dmoz/Business/Financial Services/Cash Flow", "wgt": 100}, {"uri": "dmoz/Business/Major_Companies", "label": "dmoz/Business/Major Companies", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 96}], "articleCounts": {"eng": 5}, "sentiment": 0.3490196078431373, "wgt": 449193600, "relevance": 1}